Should autologous HSCT be a first-line option in highly active MS: YES

Multiple Sclerosis Journal 2026

View at publisher

Authors: Alice Mariottini, Paolo Antonio Muraro

DOI: 10.1177/13524585261439669

Cited by: 1

References: 8

Fields of Study & Subjects

Multiple Sclerosis Research Studies Polyomavirus and related diseases Genetic Neurodegenerative Diseases

References 8